SLLK, Control Peptide for TSP1 Inhibitor acetate(464924-27-4,free base) 是 LSKL 的对照肽。

SLLK, Control Peptide for TSP1 Inhibitor acetate is a control peptide for LSKL.

TGF-β1 is significantly lower (0.10±0.01 pg/mL) in the plasma of mice receiving LSKL compared with that in plasma of mice receiving SLLK control peptide at day 42 (0.20±0.02 pg/mL; P=0.0001). mRNA expression is assessed in the suprarenal aortic lysates obtained from mice receiving SLLK and LSKL peptides[1]. Akita mice treated with 30 mg/kg LSKL have significantly increased nephrin expression, greater than twofold, compared with renal lysates from either saline controls or SLLK-treated mice[2].

TP1833L

C23H46N6O7

518.66

SLLK, Control Peptide for TSP1 Inhibitor acetate(464924-27-4,free base);SLLK, Control Peptide for TSP1 Inhibitor acetate

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years